The contribution of collaboration with university and government to the competitiveness of clusters: model proposition and comparison between cases in the biomedical industry in Brazil and the UK

The contribution of collaboration with university and government to the competitiveness of clusters: model proposition and comparison between cases in the biomedical industry in Brazil and the UK (2020)

Authors:
USP affiliated authors: BOAVENTURA, JOÃO MAURICIO GAMA - FEA ; PEREIRA, CRISTINA ESPINHEIRA COSTA - FEA
Unidade: FEA
Subjects: CLUSTERS; NEGÓCIOS; INOVAÇÕES TECNOLÓGICAS
Language: Inglês
Imprenta:
- Publisher: ANPAD
- Publisher place: Rio de Janeiro
- Date published: 2020
Source:
- Título do periódico: Anais
Conference titles: Encontro da Associação Nacional de Pós-Graduação e Pesquisa em Administração - ENANPAD

A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

ABNT

PEREIRA, Cristina Espinheira Costa e BOAVENTURA, João Maurício Gama e ARMANDO, Eduardo. The contribution of collaboration with university and government to the competitiveness of clusters: model proposition and comparison between cases in the biomedical industry in Brazil and the UK. 2020, Anais.. Rio de Janeiro: ANPAD, 2020. . Acesso em: 11 maio 2024.
APA

Pereira, C. E. C., Boaventura, J. M. G., & Armando, E. (2020). The contribution of collaboration with university and government to the competitiveness of clusters: model proposition and comparison between cases in the biomedical industry in Brazil and the UK. In Anais. Rio de Janeiro: ANPAD.
NLM

Pereira CEC, Boaventura JMG, Armando E. The contribution of collaboration with university and government to the competitiveness of clusters: model proposition and comparison between cases in the biomedical industry in Brazil and the UK. Anais. 2020 ;[citado 2024 maio 11 ]
Vancouver

Pereira CEC, Boaventura JMG, Armando E. The contribution of collaboration with university and government to the competitiveness of clusters: model proposition and comparison between cases in the biomedical industry in Brazil and the UK. Anais. 2020 ;[citado 2024 maio 11 ]